Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-17-007711
Filing Date
2017-02-09
Accepted
2017-02-09 12:11:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-3986_37sc13ga.htm SC 13G/A 69733
  Complete submission text file 0001104659-17-007711.txt   71397
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SC 13G/A

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45385 | Film No.: 17586314
SIC: 2834 Pharmaceutical Preparations